US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 19.780
  • -0.980-4.72%
Close Nov 11 16:00 ET
  • 19.700
  • -0.080-0.40%
Post 18:55 ET
502.71MMarket Cap-428P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cartesian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 5.000M --
-- 2024/Q4 -- / 150.000K --
-- 2024/Q3 387.000K / 1.833M --
-- 2024/Q2 33.445M / 5.506M --
-- 2024/Q1 5.840M / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.000M--
--2024/Q4-- / 150.000K--
--2024/Q3387.000K / 1.833M--
--2024/Q233.445M / 5.506M--
--2024/Q15.840M / 0.000--

Unlock Free Earnings Estimates

Cartesian Therapeutics Earnings Reports

  • Cartesian Therapeutics | 10-Q: Quarterly report

    Nov 7 20:23

  • Cartesian Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 19:09

  • Cartesian Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 19:08

  • Cartesian Therapeutics | 10-K: FY2023 Annual Report

    Mar 7 20:14

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data